Pricing Log in Create free account

Kyverna Therapeutics, Inc. (KYTX) vs Nautilus Biotechnology, Inc. (NAUT)

Kyverna Therapeutics, Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. Kyverna Therapeutics, Inc. and Nautilus Biotechnology, Inc. are of similar size ($285.1M and $273.9M). Across the 10 metrics below, Nautilus Biotechnology, Inc. leads on 7 and Kyverna Therapeutics, Inc. on 3.

Valuation

Metric KYTX NAUT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 1.78 2.43 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (60.62%) (20.76%) (32.88%)
Free cash flow yield (53.83%) (19.43%) (23.13%)

Profitability

Metric KYTX NAUT Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (87.24%) (41.01%) (51.96%)
Return on assets (68.40%) (33.49%) (46.06%)
Return on invested capital 0.00% (133.48%) 0.00%

Growth

Metric KYTX NAUT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (9.31%) 16.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric KYTX NAUT Biotechnology median
Debt to equity 0.15 0.00 0.00
Current ratio 9.06 9.25 4.97
Net debt to EBITDA 1.51 1.67 1.01

Dividend

Metric KYTX NAUT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KYTX NAUT Biotechnology median
Market cap 285.10m 273.85m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack